tiprankstipranks
Corcept Therapeutics Inc. (DE:HTD)
FRANKFURT:HTD
Germany Market
HTD
Corcept Therapeutics
RESEARCH TOOLSreports

Corcept Therapeutics (HTD) Ratios

3 Followers

Corcept Therapeutics Ratios

DE:HTD's free cash flow for Q2 2026 was $0.98. For the 2026 fiscal year, DE:HTD's free cash flow was decreased by $ and operating cash flow was $0.18. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.86 2.92 3.35 4.39 6.89
Quick Ratio
 2.77 2.85 3.26 4.31 6.80
Cash Ratio
 0.72 0.73 0.91 1.30 0.91
Solvency Ratio
 0.31 0.54 0.88 0.93 1.26
Operating Cash Flow Ratio
 0.71 0.85 1.41 1.22 1.66
Short-Term Operating Cash Flow Coverage
 57.22 0.00 238.92 841.32 105.27
Net Current Asset Value
$ 256.75M$ 296.62M$ 310.64M$ 343.82M$ 417.67M
Leverage Ratios
Debt-to-Assets Ratio
 0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 0.01 <0.01 0.01 <0.01 <0.01
Debt-to-Capital Ratio
 0.01 <0.01 0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.01 <0.01 0.00 0.00 0.00
Financial Leverage Ratio
 1.26 1.29 1.24 1.23 1.16
Debt Service Coverage Ratio
 33.41 0.00 171.95 595.41 86.72
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 0.09 0.06 0.07 <0.01 0.01
Net Debt to EBITDA
 -3.53 -1.67 -0.74 -1.25 -0.57
Profitability Margins
Gross Profit Margin
98.30%98.30%98.39%98.66%98.66%
EBIT Margin
3.17%8.73%23.92%22.24%28.03%
EBITDA Margin
3.47%8.98%24.12%22.46%28.34%
Operating Profit Margin
0.77%5.88%20.29%22.24%28.03%
Pretax Profit Margin
3.17%8.73%23.92%25.82%28.91%
Net Profit Margin
6.61%13.09%20.70%22.00%25.24%
Continuous Operations Profit Margin
7.42%13.09%20.92%22.00%25.24%
Net Income Per EBT
208.18%149.94%86.53%85.21%87.29%
EBT Per EBIT
411.69%148.36%117.92%116.10%103.16%
Return on Assets (ROA)
6.18%11.91%16.62%17.08%17.38%
Return on Equity (ROE)
8.37%15.38%20.56%20.95%20.21%
Return on Capital Employed (ROCE)
0.87%6.68%19.57%20.75%22.04%
Return on Invested Capital (ROIC)
0.87%6.67%17.09%17.68%19.20%
Return on Tangible Assets
6.18%11.91%16.62%17.08%17.38%
Earnings Yield
0.47%2.76%2.69%3.16%4.68%
Efficiency Ratios
Receivables Turnover
 10.80 12.74 11.62 8.49 8.58
Payables Turnover
 0.94 0.32 0.71 0.37 0.45
Inventory Turnover
 1.07 1.01 0.88 0.84 0.88
Fixed Asset Turnover
 69.27 117.63 84.24 1.53K 226.27
Asset Turnover
 0.93 0.91 0.80 0.78 0.69
Working Capital Turnover Ratio
 2.95 2.34 1.97 1.24 1.24
Cash Conversion Cycle
 -10.91 -746.96 -68.02 -501.38 -355.72
Days of Sales Outstanding
 33.79 28.66 31.40 43.00 42.56
Days of Inventory Outstanding
 341.68 361.93 416.32 435.34 413.46
Days of Payables Outstanding
 386.38 1.14K 515.74 979.72 811.74
Operating Cycle
 375.47 390.59 447.72 478.34 456.02
Cash Flow Ratios
Operating Cash Flow Per Share
 1.04 1.37 1.92 1.23 1.13
Free Cash Flow Per Share
 1.01 1.37 1.90 1.23 1.12
CapEx Per Share
 0.03 <0.01 0.02 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.97 1.00 0.99 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 39.47 672.97 91.19 913.95 291.34
Capital Expenditure Coverage Ratio
 39.47 672.97 91.19 913.95 291.34
Operating Cash Flow Coverage Ratio
 11.64 23.25 28.56 841.32 105.27
Operating Cash Flow to Sales Ratio
 0.13 0.19 0.29 0.26 0.30
Free Cash Flow Yield
0.89%3.92%3.77%3.77%5.53%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 214.65 36.63 37.23 31.69 21.39
Price-to-Sales (P/S) Ratio
 14.52 4.75 7.71 6.97 5.40
Price-to-Book (P/B) Ratio
 16.67 5.58 7.65 6.64 4.32
Price-to-Free Cash Flow (P/FCF) Ratio
 112.85 25.49 26.55 26.51 18.09
Price-to-Operating Cash Flow Ratio
 107.22 25.45 26.26 26.48 18.03
Price-to-Earnings Growth (PEG) Ratio
 -3.65 -1.24 1.15 4.30 -10.37
Price-to-Fair Value
 16.67 5.58 7.65 6.64 4.32
Enterprise Value Multiple
 415.59 51.20 31.21 29.80 18.47
Enterprise Value
 11.96B 3.50B 5.08B 3.23B 2.10B
EV to EBITDA
 415.59 51.20 31.21 29.80 18.47
EV to Sales
 14.40 4.60 7.53 6.69 5.23
EV to Free Cash Flow
 111.90 24.69 25.94 25.44 17.54
EV to Operating Cash Flow
 109.06 24.65 25.65 25.41 17.48
Tangible Book Value Per Share
 6.70 6.24 6.58 4.89 4.70
Shareholders’ Equity Per Share
 6.70 6.24 6.58 4.89 4.70
Tax and Other Ratios
Effective Tax Rate
 -1.34 -0.50 0.13 0.15 0.13
Revenue Per Share
 7.88 7.33 6.54 4.66 3.76
Net Income Per Share
 0.52 0.96 1.35 1.02 0.95
Tax Burden
 2.08 1.50 0.87 0.85 0.87
Interest Burden
 1.00 1.00 1.00 1.16 1.03
Research & Development to Revenue
 0.31 0.33 0.37 0.38 0.33
SG&A to Revenue
 0.67 0.59 0.42 0.00 0.00
Stock-Based Compensation to Revenue
 -0.01 0.11 0.09 0.10 0.11
Income Quality
 0.85 1.45 1.40 1.20 1.19
Currency in USD